Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome
NCT ID: NCT04845022
Last Updated: 2021-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
81 participants
OBSERVATIONAL
2021-01-28
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemostatic Variables In Snakebite Study
NCT04520282
Waveform Analysis In Snakebite Victims With Hematotoxicity
NCT03859154
Predictive Accuracy of PLR and PNR in Detecting ETIC
NCT07046858
Haemorrhage From Severe Neck and Facial Injuries - Characteristics, Management and Outcomes
NCT07204405
The Incidence of Early Trauma Induced Coagulopathy and Hyperfibrinolysis in Severely Injured Trauma Patients in the Emergency Room: a Retrospective Cohort Study
NCT07186712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
thus patients who meet the exclusion and inclusion criteria would be followed up after 48 hours and their hemogram , RFT and LDH would be re assessed to check for presence of hemolysis , thrombocytopenia and acute kidney injury(AKI) .From the hemogram sample PBS would be prepared to check for presence of schistocytes.
Here we aim to study for incidence of TMA - defined as presence of MAHA( microangiopathic hemolytic anemia ) , thrombocytopenia and presence of AKI . MAHA is detected as drop of hb, presence of schistocytes in PBS , increase in LDH and increase in retic count. India is a tropical country and the southern state of Kerala , this study is done with the purpose of finding the prevalence of TMA among patients of snakebite brought to a tertiary care centre. Most often the victims are farmers or people from middle class. A cost effective test such as peripheral smear can help in predicting the prognosis and thereby aid in deciding whether the patient should require a multi disciplinary treatment early on and thereby play a pivotal role in saving patient life as well as provide an economical solution.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known case of bleeding disorders
* Known case of haemolytic anaemia
* Patients on antiplatelets or anticoagulants
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jubilee Mission Medical College and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MAGLIN TOMY
Junior Resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aboobacker Rafi, MD
Role: STUDY_CHAIR
Jubilee Mission Medical College and Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jubilee Mission Medical College
Thrissur, Kerala, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maglin Monica Lisa Tomy, MBBS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/21/IEC/JMMC&RI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.